Search Results - "Griffith, David E."

Non-tuberculous mycobacterial pulmonary disease by Cowman, Steven, van Ingen, Jakko, Griffith, David E, Loebinger, Michael R

“…Nontuberculous mycobacterial pulmonary disease (NTM-PD) is a challenging infection which is becoming increasingly prevalent, particularly in the elderly, for…”
Get more information

Macrolide/Azalide therapy for nodular/bronchiectatic mycobacterium avium complex lung disease by Wallace, Jr, Richard J, Brown-Elliott, Barbara A, McNulty, Steven, Philley, Julie V, Killingley, Jessica, Wilson, Rebecca W, York, Deanna S, Shepherd, Sara, Griffith, David E

“…There is no large study validating the appropriateness of current treatment guidelines for Mycobacterium avium complex (MAC) lung disease. This is a…”
Get more information

Management of Mycobacterium avium complex and Mycobacterium abscessus pulmonary disease: therapeutic advances and emerging treatments by Kumar, Kartik, Daley, Charles L., Griffith, David E., Loebinger, Michael R.

“…Nontuberculous mycobacterial pulmonary disease (NTM-PD) remains a challenging condition to diagnose and treat effectively. Treatment of NTM-PD is prolonged,…”
Get full text

Randomized Trial of Liposomal Amikacin for Inhalation in Nontuberculous Mycobacterial Lung Disease by Olivier, Kenneth N., Griffith, David E., Eagle, Gina, McGinnis, John P., Micioni, Liza, Liu, Keith, Daley, Charles L., Winthrop, Kevin L., Ruoss, Stephen, Addrizzo-Harris, Doreen J., Flume, Patrick A., Dorgan, Daniel, Salathe, Matthias, Brown-Elliott, Barbara A., Gupta, Renu, Wallace, Richard J.

“…Lengthy, multidrug, toxic, and low-efficacy regimens limit management of pulmonary nontuberculous mycobacterial disease. In this phase II study, we…”
Get full text

Preliminary Results of Bedaquiline as Salvage Therapy for Patients With Nontuberculous Mycobacterial Lung Disease by Philley, Julie V, Wallace, Jr, Richard J, Benwill, Jeana L, Taskar, Varsha, Brown-Elliott, Barbara A, Thakkar, Foram, Aksamit, Timothy R, Griffith, David E

“…Bedaquiline is an oral antimycobacterial agent belonging to a new class of drugs called diarylquinolines. It has low equivalent minimal inhibitory…”
Get more information

Nontuberculous mycobacterial (NTM) lung disease: The top ten essentials by Aksamit, Timothy R., Philley, Julie V., Griffith, David E.

“…This review will utilize essential questions about nontuberculous mycobacterial (NTM) lung disease to succinctly address important new developments in the…”
Get full text

Comparative risks of chronic inhaled corticosteroids and macrolides for bronchiectasis by Henkle, Emily, Curtis, Jeffrey R, Chen, Lang, Chan, Benjamin, Aksamit, Timothy R, Daley, Charles L, Griffith, David E, Winthrop, Kevin L

“…Non-cystic fibrosis (CF) bronchiectasis ("bronchiectasis") is a chronic airway disease for which little data exist to inform treatment decisions. We sought to…”
Get more information

In vitro activity of amikacin against isolates of Mycobacterium avium complex with proposed MIC breakpoints and finding of a 16S rRNA gene mutation in treated isolates by Brown-Elliott, Barbara A, Iakhiaeva, Elena, Griffith, David E, Woods, Gail L, Stout, Jason E, Wolfe, Cameron R, Turenne, Christine Y, Wallace, Jr, Richard J

“…Amikacin is a major drug used for the treatment of Mycobacterium avium complex (MAC) disease, but standard laboratory guidelines for susceptibility testing are…”
Get more information

Epidemiology of nontuberculous mycobacterial pulmonary disease in Europe and Japan by Delphi estimation by Schildkraut, Jodie A, Gallagher, Jack, Morimoto, Kozo, Lange, Christoph, Haworth, Charles, Floto, R Andres, Hoefsloot, Wouter, Griffith, David E, Wagner, Dirk, Ingen, Jakko van

“…Nontuberculous mycobacterial pulmonary disease (NTM-PD) is an emerging opportunistic infection, but basic epidemiological data are lacking in most regions. We…”
Get more information

Amikacin Liposome Inhalation Suspension for Mycobacterium avium Complex Lung Disease: A 12-Month Open-Label Extension Clinical Trial by Winthrop, Kevin L, Flume, Patrick A, Thomson, Rachel, Mange, Kevin C, Yuen, Dayton W, Ciesielska, Monika, Morimoto, Kozo, Ruoss, Stephen J, Codecasa, Luigi R, Yim, Jae-Joon, Marras, Theodore K, van Ingen, Jakko, Wallace, Richard J, Brown-Elliott, Barbara A, Coulter, Chris, Griffith, David E

“…Rationale: Patients with refractory Mycobacterium avium complex (MAC) lung disease have limited treatment options. In the CONVERT study, amikacin liposome…”
Get more information

Treatment of slowly growing mycobacteria by Philley, Julie V, Griffith, David E

“…The most common nontuberculous mycobacterial (NTM) lung pathogen, Mycobacterium avium complex (MAC), requires antibiotic treatment regimens that are long and…”
Get more information

Therapy of refractory nontuberculous mycobacterial lung disease by Griffith, David E, Aksamit, Timothy R

“…The prevalence of nontuberculous mycobacterial (NTM) lung disease is increasing in the USA. Clinicians are therefore encountering these patients with…”
Get more information

Mycobacterium abscessus Meningitis Associated with Stem Cell Treatment During Medical Tourism by Wolf, Andrew B., Money, Kelli M., Chandnani, Arun, Daley, Charles L., Griffith, David E., Chauhan, Lakshmi, Coffman, Nathan, Piquet, Amanda L., Tyler, Kenneth L., Zimmer, Shanta M., Montague, Brian T., Mann, Sarah, Pastula, Daniel M.

“…Mycobacterium abscessus infections have been reported as adverse events related to medical tourism. We report M. abscessus meningitis in a patient who traveled…”
Get full text

Mycobacterium abscessus . “Pleased to Meet You, Hope You Guess My Name...” by Griffith, David E., Brown-Elliott, Barbara A., L. Benwill, Jeana, Wallace, Richard J.

“…Mycobacterium abscessus is a formidable and difficult-to-treat mycobacterial pathogen with multiple drug-resistance mechanisms. The most important of these…”
Get full text

Understanding the development of tuberculous granulomas: insights into host protection and pathogenesis, a review in humans and animals by Lyu, Jiwon, Narum, Drew E., Baldwin, Susan L., Larsen, Sasha E., Bai, Xiyuan, Griffith, David E., Dartois, Véronique, Naidoo, Threnesan, Steyn, Adrie J. C., Coler, Rhea N., Chan, Edward D.

“…Granulomas, organized aggregates of immune cells which form in response to Mycobacterium tuberculosis ( Mtb ), are characteristic but not exclusive of…”
Get full text

The significance of Mycobacterium abscessus subspecies abscessus isolation during Mycobacterium avium complex lung disease therapy by Griffith, David E, Philley, Julie V, Brown-Elliott, Barbara A, Benwill, Jeana L, Shepherd, Sara, York, Deanna, Wallace, Jr, Richard J

“…Isolation of Mycobacterium abscessus subspecies abscessus (MAA) is common during Mycobacterium avium complex (MAC) lung disease therapy, but there is limited…”
Get more information

Real-World Patients’ Diagnosis-to-Treatment Journey with Nontuberculous Mycobacterial Pulmonary Disease: A Cross-Sectional Survey by Morimoto, Kozo, Gallagher, Jack R., Wagner, Dirk, Griffith, David E., van Ingen, Jakko

“…Introduction The incidence and prevalence of nontuberculous mycobacterial pulmonary disease (NTM-PD) are increasing globally. Approximately 80% of NTM-PD cases…”
Get full text

Medical Management of Pulmonary Nontuberculous Mycobacterial Disease by Philley, Julie V, Griffith, David E

“…Nontuberculous mycobacterial (NTM) lung infections are increasingly recognized as a cause of chronic pulmonary disease. This article focuses on the most common…”
Get more information

Clinical and Molecular Analysis of Macrolide Resistance in Mycobacterium avium Complex Lung Disease by Griffith, David E, Brown-Elliott, Barbara A, Langsjoen, Brett, Zhang, Yansheng, Pan, Xi, Girard, William, Nelson, Kenwyn, Caccitolo, James, Alvarez, Julio, Shepherd, Sara, Wilson, Rebecca, Graviss, Edward A, Wallace, Richard J., Jr

“…The clinical features and outcome of macrolide-resistant Mycobacterium avium complex (MAC) lung disease are not known. Characterize patients, treatment, and…”
Get full text

The tolerability of linezolid in the treatment of nontuberculous mycobacterial disease by Winthrop, Kevin L, Ku, Jennifer H, Marras, Theodore K, Griffith, David E, Daley, Charles L, Olivier, Kenneth N, Aksamit, Timothy R, Varley, Cara D, Mackey, Katherine, Prevots, D Rebecca

Get more information